Beckman Coulter Diagnostics has announced a €10 million investment for its manufacturing and research base in County Clare, Ireland, that underscores its commitment to innovation and growth in the region.
The investment will enhance Beckman Coulter’s production with the addition of two new fully automated reagent filling lines and upgrades to the site’s infrastructure, boosting both efficiency and capacity.
The company is actively hiring for 50 open roles and also announced 30 additional jobs arising, to be recruited between 2025 and 2027 for highly skilled professionals at its Co. Clare facility for key functions such as production operations, quality and regulatory affairs, research and development, and more.
A special event at Beckman Coulter’s high-tech site at O´Callaghan´s Mills, Co. Clare was attended by Beckman Coulter’s Ireland-born president Kevin O’Reilly, who was appointed earlier this year to lead the company and its 11,000 employees globally. Others in attendance included European Commissioner-designate Michael McGrath, as well as other national and local public representatives and industry stakeholders.
Kevin O’Reilly is pictured above (far left) with (left-right): Mary Buckley, Executive Director of foreign direct investment agency IDA Ireland; Michael McGrath; and Orlaith Lawler, Beckman Coulter Diagnostics’ VP of Operations EMEAI.
Beckman Coulter’s economic contribution is highly significant to East Clare and the wider Mid-West region thanks to the 560 jobs it provides in its facility. Employment at the site is anticipated to rise to over 600 jobs, with headcount figures having almost doubled since 2018.
Beckman Coulter is a shining example of how cutting-edge foreign direct investment in Ireland can coexist in harmony with its precious environment. In fact, beyond its people, the company also recognises its responsibilities to local farmland, with its 15,900m2 facility located within a 120Ha farmland. A focus on sustainability at the site has led to the company making use of renewable energy, as well as a wormery waste treatment plant, water treatment plant, development of a 5km nature trail, and supporting the farmland ecosystem with over 240,000 bees living on-site.
“I'm incredibly happy about Beckman Coulter's significant contributions to my home country, Ireland, not only to the local economy but also to enhancing healthcare every day,” said Kevin O’Reilly, President of Beckman Coulter Diagnostics.
EU Commissioner-designate Michael McGrath added: “Beckman Coulter is a superb case study of the impact of foreign direct investment in Ireland, including into rural communities. There are few settings more rural for an FDI than this site in East Clare. Yet the Beckman Coulter produces cutting-edge diagnostic tools here that are critical to the delivery of healthcare across the globe and at the same time makes a massive economic impact on this area. This reflects brilliantly on Beckman Coulter, on the skills pool available in Ireland and on how big industry and the environment can cohabit perfectly here.”